Stratasys Ltd. provides connected and polymer-based 3D printing solutions. It offers 3D printing systems, such as polyjet printers, FDM printers, stereolithography printing systems, and programmable photo polymerization printers for rapid prototyping, such as design validation, visualization, and communication. The company also provides 3D printing materials, including approximately FDM spool-based filament materials, polyjet cartridge-based resin materials, non-color digital materials, and color variations for use in 3D printers and production systems. In addition, it offers GrabCAD Print Platform that offers job programming, scheduling, monitoring, order management, and analytics across various 3D printing technologies. Further, the company operates Thingiverse.com, an online community for sharing downloadable and digital 3D designs; and GrabCAD Community for mechanical engineers, designers, manufacturers, and students. Its products and services are primarily used in the automotive, aerospace, medical, dental, education, and consumer goods markets. The company sells its products through a network of resellers and independent sales agents worldwide. Stratasys Ltd. was incorporated in 1989 and is headquartered in Eden Prairie, Minnesota.
IPO Year: 1994
Exchange: NASDAQ
Website: stratasys.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
2/13/2024 | $24.00 | Overweight | Cantor Fitzgerald |
1/4/2023 | $15.00 | Hold → Buy | Needham |
11/8/2022 | Underperform → Mkt Perform | William Blair | |
8/17/2022 | $24.00 | Outperform | Credit Suisse |
5/17/2022 | $25.00 → $23.00 | Underweight → Neutral | JP Morgan |
2/24/2022 | $30.00 | Hold → Buy | Cross Research |
11/4/2021 | Neutral → Underweight | JP Morgan | |
11/4/2021 | Overweight → Neutral | JP Morgan | |
10/25/2021 | $27.00 → $42.00 | Hold → Buy | Craig Hallum |
Fourth quarter revenue of $150.4 million, compared to $156.3 million in the prior year period Fourth quarter GAAP net loss of $41.9 million, or $0.59 per diluted share, which includes $30.1 million non-cash impairment of an equity investment Fourth quarter Non-GAAP net income of $8.5 million, or $0.12 per diluted share Full year revenue of $572.5 million, compared to $627.6 million in 2023 Full year GAAP net loss of $120.3 million, or $1.70 per diluted share, and non-GAAP net income of $4.2 million, or $0.06 per diluted share Fourth quarter positive operating cash flow of $7.4 million Full year positive operating cash flow of $7.8 million, resulting in $150.7 million cash equiv
Schedules Fourth Quarter 2024 Conference Call for 8:30 a.m. ET on Wednesday, March 5, 2025 Stratasys Ltd. (NASDAQ:SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced unaudited preliminary approximate financial results for the fourth quarter 2024. Preliminary Fourth Quarter 2024 Results Revenue of $150.1 to $150.5 million, with hardware sequentially higher and consumables sequentially lower compared to the third quarter of 2024 GAAP gross margin of 46.0% to 46.5%, non-GAAP gross margin of 49.4% to 49.7%. GAAP operating loss of $13.3 to $14.4 million, non-GAAP operating income of $9.0 to $9.5 million GAAP net loss of $15.3 to $16.5
-Promising results obtained from the pre-clinical study with CollPlant's commercial sized rhCollagen-based regenerative breast implants, demonstrating significant implant vascularization and rapid ingrowth of native tissue -Innovative breast implant technology designed to address a $3.0 billion market opportunity -Cash and cash equivalents balance as of September 30, 2024 was $15.4 million -Conference call to be held today at 10:00 a.m. U.S. EDT – REHOVOT, Israel, Nov. 27, 2024 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration
Raises 2024 Margins and Profitability Outlook Revenue of $140.0 million, compared to $162.1 million in third quarter 2023 Eighth consecutive quarter of year-over-year growth in recurring consumables revenue reflects continued strong printer utilization Improved GAAP gross margin by 430bps to 44.8% and non-GAAP gross margin by 130bps to 49.6% compared to third quarter 2023 GAAP net loss of $26.6 million, or $0.37 per diluted share; non-GAAP net income resumes achieving profitability with $0.4 million, or $0.01 per diluted share $4.5 million of cash used in operations; year-to-date operating cash flow remains positive Adjusted EBITDA of $5.1 million Restructuring cost sa
Stratasys Ltd. (NASDAQ:SSYS) will release financial results for the third quarter ended September 30, 2024, on Wednesday, November 13, 2024. The Company plans to hold the conference call to discuss its third quarter 2024 financial results on Wednesday, November 13, 2024, at 8:30 a.m. (ET). The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com; or directly at the following web address: https://event.choruscall.com/mediaframe/webcast.html?webcastid=xEC56y1o To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least
Revenue of $138.0 million, compared to $159.8 million ($154.6 million net of divestments) in second quarter 2023, related to ongoing impact of current macroeconomic environment on customer capital equipment purchasing Year-over-year growth in recurring consumables revenue of 6.3% reflects continued strong printer utilization Improved GAAP gross margin by 230bps and non-GAAP gross margin by 50bps compared to second quarter 2023. GAAP net loss of $25.7 million, or $0.36 per diluted share, and non-GAAP net loss of $3.0 million, or $0.04 per diluted share $2.4 million in cash used in operations and negative free cash flow of $5.4 million Completes strategic review process and an
- Recently initiated a pre-clinical trial with CollPlant's rhCollagen-based regenerative breast implants, printed with Stratasys' Origin® 3D printer that are 200cc in volume - Breast implants could address a $3.0 billion market opportunity - Cash and cash equivalents balance as of June 30, 2024 was $18.9 million - Conference call to be held today at 10:00 a.m. U.S. EDT REHOVOT, Israel, Aug. 20, 2024 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced financial results for the second quarter
Stratasys Ltd. (NASDAQ:SSYS) will release financial results for the second quarter ended June 30, 2024, on Thursday, August 29, 2024. The Company plans to hold the conference call to discuss its second quarter 2024 financial results on Thursday, August 29, 2024, at 8:30 a.m. (ET). The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com; or directly at the following web address: https://event.choruscall.com/mediaframe/webcast.html?webcastid=2xc8Kb5W To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten m
Revenue of $144.1 million, flat year over year excluding the impact of divestitures Record recurring consumables revenue reflects continued strong printer utilization GAAP net loss of $26.0 million, or $0.37 per diluted share, and non-GAAP net loss of $1.7 million, or $0.02 per diluted share $7.3 million in cash generated from operations and positive free cash flow of $4.3 million Strong F3300 pipeline ahead of expectations Reiterates 2024 outlook Stratasys Ltd. (NASDAQ:SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced financial results for the first quarter 2024. First Quarter 2024 Financial Results Compared to First Quart
Stratasys Ltd. (NASDAQ:SSYS) will release financial results for the first quarter ended March 31, 2024, after market close on Wednesday, May 29, 2024. The Company plans to hold the conference call to discuss its first quarter 2024 financial results on Wednesday, May 29, 2024, at 5:00 p.m. (ET). The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com; or directly at the following web address: https://event.choruscall.com/mediaframe/webcast.html?webcastid=H13Rjkjs To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call
Stratasys Ltd. (NASDAQ:SSYS), announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission (the "SEC"). The annual report on Form 20-F, which contains Stratasys' audited annual financial statements for 2024, can be accessed on the SEC's website at http://www.sec.gov, as well as via the Company's investor relations website at http://investors.stratasys.com/financial-information. The Company will deliver a hard copy of its 2024 annual report on Form 20-F, including its complete audited financial statements, free of charge to its shareholders, upon request to Yonah Lloyd, Chief Communications Offic
Fourth quarter revenue of $150.4 million, compared to $156.3 million in the prior year period Fourth quarter GAAP net loss of $41.9 million, or $0.59 per diluted share, which includes $30.1 million non-cash impairment of an equity investment Fourth quarter Non-GAAP net income of $8.5 million, or $0.12 per diluted share Full year revenue of $572.5 million, compared to $627.6 million in 2023 Full year GAAP net loss of $120.3 million, or $1.70 per diluted share, and non-GAAP net income of $4.2 million, or $0.06 per diluted share Fourth quarter positive operating cash flow of $7.4 million Full year positive operating cash flow of $7.8 million, resulting in $150.7 million cash equiv
Stratasys Sets Important ESG Standards in the 3D Printing Industry The Company is a Top Choice Sustainable Additive Manufacturing Operations and Solutions Provider Stratasys Ltd. announced today that it received its first-ever EcoVadis certification, achieving a Silver sustainability rating, placing in the 90th percentile joining the top 10% of all companies assessed globally. This milestone displays the company's dedication to responsible business practices that create a positive impact on the environment, society, and all stakeholders. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250226688746/en/Stratasys achieved a Silv
Anatomically accurate 3D-printed phantoms replace cadavers, transforming CT imaging and AI algorithm training Stratasys Ltd. (NASDAQ:SSYS) and Siemens Healthineers recently presented the results of a joint research effort that demonstrates the unprecedented accuracy of the solutions offered by Stratasys to enable 3D-printed medical imaging phantoms to replicate human anatomy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250225460488/en/Stratasys and Siemens Healthineers Bring a New Era for Medical Imaging Research With Patient-Specific 3D-Printed Phantoms (Photo: Business Wire) This collaborative effort uses Stratasys' Radio
The integration of Stratasys' J850 TechStyle™ solution empowers NYES to deliver innovative and sustainable fashion for global designers Stratasys (NASDAQ:SSYS) today announced that New York Embroidery Studio (NYES) has integrated the Stratasys J850 TechStyle™ printer into its manufacturing capabilities. Known for its innovation in design and production, NYES is leveraging this 3D Fashion® direct-to-textile printing technology to combine traditional embroidery with cutting-edge 3D printing, enabling new levels of creativity, personalization, and eco-conscious manufacturing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250218604
Stratasys Direct's New ISO 13485 Certification Meets Stringent Regulatory Requirements Essential for Medical Device Manufacturers Stratasys Ltd. (NASDAQ:SSYS) today announced that its Stratasys Direct manufacturing facility in Tuscon, Arizona has achieved ISO 13485 certification, a globally recognized standard for quality management systems in medical device manufacturing. Stratasys plans to extend this certification to its other Stratasys Direct manufacturing facilities in Texas and Minnesota. By achieving ISO 13485 certification, Stratasys Direct is formally recognized for its safety, precision, and reliability of its 3D-printed components. This certification addresses critical regula
Schedules Fourth Quarter 2024 Conference Call for 8:30 a.m. ET on Wednesday, March 5, 2025 Stratasys Ltd. (NASDAQ:SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced unaudited preliminary approximate financial results for the fourth quarter 2024. Preliminary Fourth Quarter 2024 Results Revenue of $150.1 to $150.5 million, with hardware sequentially higher and consumables sequentially lower compared to the third quarter of 2024 GAAP gross margin of 46.0% to 46.5%, non-GAAP gross margin of 49.4% to 49.7%. GAAP operating loss of $13.3 to $14.4 million, non-GAAP operating income of $9.0 to $9.5 million GAAP net loss of $15.3 to $16.5
Transaction at a Premium Underscores Leading Position in the Additive Manufacturing Industry and Positions Stratasys to Drive Growth Strengthens Balance Sheet to Capture Market Opportunities Fortissimo's Founding and Managing Partner, Yuval Cohen, to Join the Stratasys Board Stratasys Ltd. (NASDAQ:SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced that Fortissimo Capital ("Fortissimo"), a leading Israeli private equity fund investing in technology and industrials, has entered into an agreement to invest $120 million in the Company, acquiring approximately 14% of Stratasys' issued and outstanding ordinary shares through a direct purchase of
TrueDent-D™ resin is now available in major European markets that require CE marking, with strong customer interest already building Stratasys (NASDAQ:SSYS) has declared that its TrueDent-D™ resin is available for sale in Europe as a CE Mark Class I medical device. This milestone enables the sale of its TrueDent™ monolithic multi-shade digital denture solution in European countries that require CE marking. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250114856677/en/Stratasys Launches TrueDent™ in Europe (Photo: Business Wire) Following its successful debut in the United States in 2023, TrueDent is now set to deliver a scala
Stratasys highlights achievements in environmental, social, and governance initiatives, cementing its position as a supplier of choice for sustainable AM-enabled production solutions. Stratasys Ltd. (NASDAQ:SSYS) today announced the publication of its third Mindful Manufacturing™ ESG (Environment, Social, and Governance) and Sustainability Report. Prepared in accordance with the Global Reporting Initiative (GRI) and referencing SASB (Sustainability Accounting Standards Board) standards, the report underscores Stratasys' commitment to ESG excellence and enterprise risk management through best-in-class corporate governance, a people-first approach, meaningful social impact, and robust envir
S-8 - STRATASYS LTD. (0001517396) (Filer)
20-F - STRATASYS LTD. (0001517396) (Filer)
6-K - STRATASYS LTD. (0001517396) (Filer)
6-K - STRATASYS LTD. (0001517396) (Filer)
6-K - STRATASYS LTD. (0001517396) (Filer)
8-A12B/A - STRATASYS LTD. (0001517396) (Filer)
6-K - STRATASYS LTD. (0001517396) (Filer)
6-K - STRATASYS LTD. (0001517396) (Filer)
6-K - STRATASYS LTD. (0001517396) (Filer)
6-K - STRATASYS LTD. (0001517396) (Filer)
Cantor Fitzgerald initiated coverage of Stratasys with a rating of Overweight and set a new price target of $24.00
Needham upgraded Stratasys from Hold to Buy and set a new price target of $15.00
William Blair upgraded Stratasys from Underperform to Mkt Perform
Credit Suisse initiated coverage of Stratasys with a rating of Outperform and set a new price target of $24.00
JP Morgan upgraded Stratasys from Underweight to Neutral and set a new price target of $23.00 from $25.00 previously
Cross Research upgraded Stratasys from Hold to Buy and set a new price target of $30.00
JP Morgan downgraded Stratasys from Neutral to Underweight
JP Morgan downgraded Stratasys from Overweight to Neutral
Craig Hallum upgraded Stratasys from Hold to Buy and set a new price target of $42.00 from $27.00 previously
JPMorgan Chase & Co. upgraded Stratasys from Underweight to Neutral and set a new price target of $29.00
SC 13G/A - STRATASYS LTD. (0001517396) (Subject)
SC 13G/A - STRATASYS LTD. (0001517396) (Subject)
SC 13G/A - STRATASYS LTD. (0001517396) (Subject)
SC 13D - STRATASYS LTD. (0001517396) (Subject)
SC 13D/A - STRATASYS LTD. (0001517396) (Subject)
SC 13G - STRATASYS LTD. (0001517396) (Subject)
SC 13G/A - STRATASYS LTD. (0001517396) (Subject)
SC 13G - STRATASYS LTD. (0001517396) (Subject)
SC 13G - STRATASYS LTD. (0001517396) (Subject)
SC 13D - STRATASYS LTD. (0001517396) (Subject)
Transaction at a Premium Underscores Leading Position in the Additive Manufacturing Industry and Positions Stratasys to Drive Growth Strengthens Balance Sheet to Capture Market Opportunities Fortissimo's Founding and Managing Partner, Yuval Cohen, to Join the Stratasys Board Stratasys Ltd. (NASDAQ:SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced that Fortissimo Capital ("Fortissimo"), a leading Israeli private equity fund investing in technology and industrials, has entered into an agreement to invest $120 million in the Company, acquiring approximately 14% of Stratasys' issued and outstanding ordinary shares through a direct purchase of
Stratasys highlights achievements in environmental, social, and governance initiatives, cementing its position as a supplier of choice for sustainable AM-enabled production solutions. Stratasys Ltd. (NASDAQ:SSYS) today announced the publication of its third Mindful Manufacturing™ ESG (Environment, Social, and Governance) and Sustainability Report. Prepared in accordance with the Global Reporting Initiative (GRI) and referencing SASB (Sustainability Accounting Standards Board) standards, the report underscores Stratasys' commitment to ESG excellence and enterprise risk management through best-in-class corporate governance, a people-first approach, meaningful social impact, and robust envir
Medical facilities and device manufacturers previously limited by constraints can now create patient-specific models to enhance surgical preparation, elevate patient outcomes, and fast-track innovation Stratasys Ltd. (NASDAQ:SSYS) today announced the launch of its J5™ Digital Anatomy™ 3D printer, the latest innovation designed to address the growing demand for cost-effective, high-fidelity anatomical models. This Stratasys innovation is designed to enable hospitals, medical device manufacturers and research institutions to enhance patient outcomes, streamline operations and bring products to market faster. This press release features multimedia. View the full release here: https://www.bu
Appointment of Amir Kleiner will strengthen the connection between the Customer Success organization and the Operations and Supply Chain divisions Stratasys Ltd. (NASDAQ:SSYS) today announced the appointment of Amir Kleiner as Chief Operating Officer. The 12-year Stratasys veteran will lead the company's Global Operations, MIS, and Quality team, while continuing to manage the Customer Success team. The appointment is set to strengthen the connection between the Customer Success organization and the Operations and Supply Chain divisions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240408469494/en/Amir Kleiner, Chief Operatin
Stratasys Ltd. (NASDAQ:SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced that it has appointed Aris Kekedjian as an independent member of the Company's Board of Directors, effective immediately. Mr. Kekedjian replaces Ziva Patir, who has decided to step down from the Company's Board following ten years of service as a director. With this appointment, the Board will continue to comprise eight directors, seven of whom are independent. Mr. Kekedjian is an established executive who brings more than 30 years of leadership expertise across business development, M&A and operations of complex cross-border businesses at scale. He currently serves as C
AMGTA Lifecyle Research report highlights Stratasys's work with the Dyloan Bond Factory, a Pattern Group Company in the comparison of additive manufacturing vs. traditional production processes Evidence revealed that a Stratasys PolyJet™ material jetting approach can cut CO2e emissions by 24.8% in comparison to injection molding and save 48% of stock material across the supply chain Stratasys Ltd. (NASDAQ:SSYS) shared the results of a study commissioned by the Additive Manufacturer Green Trade Association (AMGTA), that demonstrates the environmental benefits of additive manufacturing for the fashion industry. This press release features multimedia. View the full release here: https://w
Court rules that Nano Dimension's Board Has Full Authority to Proceed with the Stratasys Transaction. Stratasys Deprive THEIR Shareholders of Immediate and Guaranteed Cash ReturnNano Dimension is Committed to Consummate a Transaction with Stratasys Waltham, Mass., April 19, 2023 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM, "Nano Dimension", "NANO" or the "Company"))), a leading supplier of Additively Manufactured Electronics ("AME") and multi-dimensional polymer, metal & ceramic Additive Manufacturing ("AM") 3D printers, today responded to the statement released by Stratasys Ltd. (NASDAQ:SSYS) on April 18th, 2023: "It is d
Believes the Stern-Controlled Board's Decision to Challenge Our Special Meeting Demand – Without Any Valid Justification – Reinforces the Need for Objective and Independent Perspectives in the Boardroom Contends the Company is Making Misleading Claims About Murchinson to Distract from Mr. Stern Having Presided Over a More Than 77% Share Price Decline Since Becoming Chairman Puts Forward Proposals to Remove Four Incumbents and Appoint Two Highly Qualified, Independent Director Candidates with Sorely Needed Capital Allocation Acumen and Corporate Governance Expertise Sees a Clear Opportunity to Optimize Nano Dimension's Overcapitalized Balance Sheet, Explore Strategic Options to Maximize V